JP2025515833A5 - - Google Patents
Info
- Publication number
- JP2025515833A5 JP2025515833A5 JP2024566738A JP2024566738A JP2025515833A5 JP 2025515833 A5 JP2025515833 A5 JP 2025515833A5 JP 2024566738 A JP2024566738 A JP 2024566738A JP 2024566738 A JP2024566738 A JP 2024566738A JP 2025515833 A5 JP2025515833 A5 JP 2025515833A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- methyl
- compound
- formula
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22173211.8 | 2022-05-13 | ||
| EP22173211 | 2022-05-13 | ||
| EP22175324 | 2022-05-25 | ||
| EP22175324.7 | 2022-05-25 | ||
| PCT/EP2023/062529 WO2023217923A1 (en) | 2022-05-13 | 2023-05-11 | New indazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515833A JP2025515833A (ja) | 2025-05-20 |
| JP2025515833A5 true JP2025515833A5 (enExample) | 2026-05-18 |
Family
ID=86604076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024566738A Pending JP2025515833A (ja) | 2022-05-13 | 2023-05-11 | 新規インダゾール誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250313565A1 (enExample) |
| EP (1) | EP4522617A1 (enExample) |
| JP (1) | JP2025515833A (enExample) |
| KR (1) | KR20250012058A (enExample) |
| CN (1) | CN119173518A (enExample) |
| AR (1) | AR129307A1 (enExample) |
| AU (1) | AU2023269227A1 (enExample) |
| CA (1) | CA3256325A1 (enExample) |
| TW (1) | TW202402276A (enExample) |
| WO (1) | WO2023217923A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020254565A1 (en) | 2019-06-21 | 2020-12-24 | F. Hoffmann-La Roche Ag | Egfr inhibitors for the treatment of cancer |
| WO2022117475A1 (en) | 2020-12-01 | 2022-06-09 | F. Hoffmann-La Roche Ag | New indazole derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020254565A1 (en) * | 2019-06-21 | 2020-12-24 | F. Hoffmann-La Roche Ag | Egfr inhibitors for the treatment of cancer |
-
2023
- 2023-05-11 EP EP23726341.3A patent/EP4522617A1/en active Pending
- 2023-05-11 US US18/865,278 patent/US20250313565A1/en active Pending
- 2023-05-11 AU AU2023269227A patent/AU2023269227A1/en active Pending
- 2023-05-11 JP JP2024566738A patent/JP2025515833A/ja active Pending
- 2023-05-11 CN CN202380039816.2A patent/CN119173518A/zh active Pending
- 2023-05-11 KR KR1020247037659A patent/KR20250012058A/ko active Pending
- 2023-05-11 CA CA3256325A patent/CA3256325A1/en active Pending
- 2023-05-11 WO PCT/EP2023/062529 patent/WO2023217923A1/en not_active Ceased
- 2023-05-12 TW TW112117717A patent/TW202402276A/zh unknown
- 2023-05-12 AR ARP230101177A patent/AR129307A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7326622B2 (ja) | Ｅｒｋ阻害剤としてのスピロ系化合物およびその使用 | |
| JP2023506691A5 (enExample) | ||
| JP2019510787A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| JP2015536940A (ja) | 抗ウイルス性ホスホネート類似体及びその製造方法 | |
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP2009531441A5 (enExample) | ||
| US11945785B2 (en) | Pyrazine compounds as inhibitors of FLT3 | |
| JP2018513832A5 (enExample) | ||
| JP2024517765A (ja) | インテグリン阻害剤の拡大投与レジメン | |
| JP6872179B2 (ja) | テノホビルプロドラッグの新規な多結晶形並びにその製造方法及び用途 | |
| JP2007514691A5 (enExample) | ||
| JP2023517312A5 (enExample) | ||
| JP2023517043A5 (enExample) | ||
| JP2004525178A5 (enExample) | ||
| JP2005516898A5 (enExample) | ||
| WO2002020539A1 (en) | Adenosine derivatives and use thereof | |
| JP2008508251A5 (enExample) | ||
| JP2005526073A5 (enExample) | ||
| CN111936488B (zh) | 用于治疗寄生虫感染的新颖化合物 | |
| JPS6287574A (ja) | 新規なｎ置換３，４−ジヒドロピリミジン−２−オン誘導体、その製造法及び循環器系疾患治療剤 | |
| JP6545254B2 (ja) | リン含有フェナントロリン誘導体及びその調製方法と応用 | |
| JP2017513934A5 (enExample) | ||
| JP2022521474A5 (enExample) |